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Abstract
Background: Adolescent cannabis use is associated with increased risk for psychological 
problems, with evidence for more severe problems among youth who use cannabis in combination 
with other substances (i.e., polysubstance use). Juvenile offenders engage in both cannabis use and 
polysubstance use at higher rates than the general adolescent population. Yet, limited research has 
examined the relationship between cannabis poly-use (e.g., cannabis and alcohol use) and 
functional or psychological problems among juvenile offenders.
Objectives: The current study addresses this gap by examining the association of polysubstance 
use of cannabis compared to cannabis only use with cognitive functioning, psychological distress, 
and substance-related problems among juvenile detainees.
Methods: Participants were 238 detained youth ages 12–18 (80.4% male, 77.3% non-White) who 
completed assessments of substance use, intellectual functioning, psychological symptoms, and 
substance-related problems. Youth were also assessed by a clinical psychologist for substance use 
disorder.
Results: Four cannabis-use typologies were identified; cannabis and alcohol use was the largest 
class, followed by cannabis only use, cannabis, alcohol and other drug use, then cannabis and 
other drug use. Polysubstance use was associated with lower scores on measures of intellectual 
functioning, more externalizing and internalizing symptomology, and more substance-related 
problems relative to cannabis only use. However, the relationship between polysubstance use and 
problems varied by typology.
Conclusions: Findings suggest that justice-involved youth engaged in polysubstance use may be 
at greater need for concurrent academic, affective, and behavioral support in their rehabilitation 
and transition back to the community.
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Introduction
Cannabis is the most commonly-used illicit drug among U.S. adolescents, with 30% of 
school-aged adolescents reporting any history of cannabis use in 2015 (1). Yet among 
juvenile offenders, rates of cannabis use are higher than among adolescents in general 
population studies, with lifetime rates ranging from 54% to 92% among justice-involved 
samples (2, 3). Disproportionate rates of cannabis use among juvenile offenders are 
concerning, as cannabis use during adolescence is associated with multiple functional and 
mental health problems, including poor academic achievement (4), delinquency (5), 
cognitive impairment (6, 7), psychological distress (8), and the development of substance 
use disorders (SUDs) (9). SUDs and other mental health problems associated with cannabis 
use are related to increased risk for recidivism among juvenile detainees (10, 11), suggesting 
that those who use cannabis require screening and intervention while justice-involved to 
facilitate treatment and prevent re-offending.
The high prevalence of cannabis use among juvenile offenders is not only concerning due to 
its association with mental health problems, but also due to its strong association with other 
substances among adolescents (12, 13). Thus, a body of literature has emerged examining 
adolescent polysubstance use, defined as reporting use of more than one substance within a 
specified time frame (14), ranging from same day to lifetime (15, 16). Adolescent use of 
cannabis and other substances is common. For example, within the literature on adolescent 
polysubstance use, there is evidence that youth are unlikely to use cannabis but not alcohol 
(12, 17), with several recent studies noting that the polysubstance use of cannabis and 
alcohol comprises up to 34% of nationally-representative samples of adolescents (18–20). 
Less research has examined rates of polysubstance use of cannabis and other substance 
among juvenile offenders, but data suggests that the prevalence may be much higher among 
this population. For example, among a sample of male detainees, Racz and colleagues (3) 
found that 92% of detainees used cannabis, 85% engaged in polysubstance use of cannabis 
and alcohol, 93% engaged in any type of polysubstance use, with a mean of substances three 
substances. These high rates of polysubstance use among juvenile offenders are likely to 
contribute to their high rates of SUD, as polysubstance use disorder is common among this 
population, with one study finding that 21% of offenders met criteria for both cannabis use 
disorder and another SUD (10).
Due to the prevalence of co-occurring alcohol and cannabis use among adolescents, research 
has begun to examine associated problems, with findings indicating that this type of use is 
associated with increased risk for psychological distress (21), cognitive impairments (7), and 
SUDs relative to use of a single substance among general population adolescents (17, 19). 
These relationships between substance use and mental health problems have been supported 
by several models, including animal models demonstrating the deleterious effects of 
cannabis on adolescent learning (22), and theories such as the dual pathway deviance-
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proneness models, which say that hazardous substance use is linked to behavioral 
disinhibition/deviance (23) and internalizing problems (24). However, little is known about 
the relationship between polysubstance use of cannabis and other substances and 
psychological comorbidities among juvenile offenders. One study among juvenile offenders 
found that those who used drugs and alcohol were more likely to have diagnoses of attention 
deficit disorder and an aggressive sub-type of conduct disorder than those who did not use 
substances (25), suggesting that the association between polysubstance use and 
psychological problems may also hold among this high-risk population, although the study 
did not explicitly examine cannabis and alcohol polysubstance use.
However, as research examining the psychological problems related to polysubstance use is 
fairly nascent, few studies have compared polysubstance use to single substance use, to 
examine whether these models hold as well for polysubstance use. Moreover, to our 
knowledge, no study has examined the differential effect of polysubstance use versus single 
substance use on health problems among juvenile offenders who use substances. As juvenile 
offenders also engage in disproportionately high rates of polysubstance use (3), such work 
would help identify targets for intervention that may facilitate these adolescents’ 
rehabilitation and transition back to the community. Given the high rates of cannabis use 
among juvenile offenders, the current study will examine problems associated with 
polysubstance use among those who use cannabis.
Specifically, we will examine four substance-use typologies, or types of substances being 
used in a discrete period: cannabis only, cannabis + alcohol, cannabis + other drugs, or 
cannabis + alcohol + other drugs. Given that common problems of adolescent cannabis use 
(26) and polysubstance include cognitive impairment, psychological symptoms, and 
addiction (7, 19, 21), the current study will focus on these problems. Thus, extending upon 
findings from general adolescent populations, we hypothesize that among our sample of 
detained youth, those who engage in polysubstance use will report poorer intellectual 
functioning, internalizing symptoms, and externalizing symptoms than those who only use 
cannabis. We also hypothesize that youth who engage in polysubstance use will be more 
likely to report substance-related problems, including the presence of a SUD, than those who 
use cannabis only after controlling for related risk factors (i.e., substance use attitudes and 
family/peer risk).
Methods
Participants
Participants in the present sample were drawn from 287 detained youth referred for 
psychological assessment by the juvenile court in a large Mid-western U.S. city from 
October 2010 to July 2016. Assessments were completed by representatives from a local 
university who were contracted by the juvenile court. Youth provided voluntary consent to 
undergo psychological testing and assessment by the university on behalf of the juvenile 
court; youth also consented to the university managing the collected data and sharing it with 
the juvenile courts. We then received Institutional Review Board approval to code and de-
identify this archival assessment data to be used for research purposes. Participants were 
ages 12–18 and reported past-year use of cannabis prior to detention, as those who did not 
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report past-year cannabis use prior to detention were excluded. Of the 287 youth assessed, 
271 provided data regarding substance use; 21 of these youth reported abstinence in the past 
year and 12 reported substance use, but not cannabis use (alcohol only use [n = 9], alcohol 
and other illicit drug use [n = 2], and cocaine only use [n=1]). Thus, the prevalence of 
cannabis use among the valid substance use data was 87.8%. Most participants (N = 238) 
were male (81.1%) and non-White (75.6%; 67.6% African American/Black, 3.8% Hispanic/
Latino, and 4.2% multiracial). The age of participants ranged from 12–18 (M =15.51).
Measures
Demographics and control variables.—Youth reported their age, gender, race, school 
enrollment status, and presence of an individualized education plan (IEP) indicating special 
education needs.
Cannabis use typology.—Past-year cannabis use and other substance use prior to 
detention was assessed by a clinician during the psychological assessment and recorded in 
the assessment report with dichotomous responses. Based on the assessment report, youth 
were then categorized in to three classes of substance use typologies based on past year 
substance use. Cannabis only (CO) users were defined as those youth reporting only using 
cannabis over the past year (n = 73), cannabis and alcohol (C+A) users were defined as 
those youth reporting using both cannabis and alcohol over the past year (n = 103), cannabis 
and other drug (C+O) users were those reporting using cannabis and at least one other drug 
use (e.g., spice, non-prescribed medication, ecstasy, methamphetamines; n = 13), and 
cannabis, alcohol, and other drug (C+A+O) users were those reporting cannabis, alcohol, 
and at least one other drug (n = 49).
Intellectual functioning.—Intellectual functioning was assessed using the Wechsler 
Intelligence Scale for Children (WISC-IV) (27). The WISC-IV is a clinician administered 
measure of intellectual functioning for youth ages 6–18 years of age used to compute a full-
scale intelligence quotient (FSIQ) and four composite scores: Verbal comprehension index 
(VCI), perceptual reasoning index (PRI), working memory index (WMI), and processing 
speed index (PSI). Index scores are computed and converted to T-scores based on a 
normative sample, with corresponding percentile rankings. Mean score for the Index scores 
is 100 (SD = 15). Composite scores have shown excellent reliability (0.88 to 0.97), test-
retest reliability (0.86–0.93), and inter-rater reliability (0.95–0.98) (28).
Internalizing and externalizing symptomology.—The Youth Self-Report (YSR) (28) 
internalizing and externalizing broad-band scales were used to assess symptoms related to 
internalizing problems (e.g., withdrawn, depressed, anxious, and somatic complaints) and 
externalizing problems (e.g., rule breaking, attention difficulties, and aggression). Youth rate 
themselves on various behavioral and emotional problems and competencies on a scale from 
0 (not true) to 2 (very often or often true). Scale scores are converted to T-scores with 
corresponding percentile rankings. T-scores < 65 on YSR scales are considered to fall in the 
“normal” range and increases in T-scores over 65 correspond with elevations in symptom 
severity. The reliability and validity of these scales are well documented (28, 29) and the 
YSR has been validated for use in samples of juvenile justice-involved youth (30).
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Substance-related problems.—Hazardous substance use was assessed through the 
Adolescent Substance Use Subtle Screening Inventory (SASSI-A2) (31), a questionnaire 
used to help determine if further assessment and/or treatment are needed for a SUD in youth. 
The SASSI-A2 Face Valid Other Drugs (FVOD) subscale was used to evaluate past year 
illicit drug use and related problems (e.g., “Spent your spare time in buying, selling, taking, 
or talking about drugs” “Gotten into trouble in school, at home, on the job, or with the police 
because of your drug use;” Miller et al., 2001). Response options range from 0 (never) to 3 
(repeatedly). Raw scores are converted to T-scores, with scores > 57 (males) and > 60 
(females) indicative of a high probability of a SUD (32).
As part of the court-ordered assessment, youth were also assessed for mental health 
diagnoses in a clinical interview, including diagnosis of a SUD. During the assessment, a 
licensed clinical psychologist assigned SUD diagnosis to youth based on criteria outlined in 
the Diagnostic and Statistical Manual of Mental Disorders-5th edition (DSM-5) (33).
Substance-related covariates.: Family/friends risk for substance use and attitudes towards 
substance use as measured by the SASSI-A2 were included as control variables, as they are 
strongly related to engagement in substance use and subsequent problems (32). The SASSI-
A2 family/friends risk scale assesses the extent to which a youth is part of a family or social 
system that fosters substance use (e.g., “I’m friends with some people that sell drugs”). 
Response options for each item are “true” or “false”, with raw scores ranging from 0–9. T-
scores > 61 (males) and > 60 (females) are indicative of a high probability of a SUD. The 
SASSI-A2 attitudes scale assesses youth’s attitudes and beliefs towards substance use (e.g. 
“Most of the people my age drink or use drugs,” “Drugs help people to be creative”. 
Response options for each item are “true” or “false”, with raw scores ranging from 0–10. 
The attitudes scale has shown excellent two-week test-retest reliability (r=.92) and good 
internal consistency (Cronbach’s alpha=.72) (32).
Procedure
Following detention by the Juvenile Court (i.e., charged with a new offense or probation 
violation), youth in the present sample were referred to the university’s medical school to 
complete a court ordered psychological assessment. Youth referred for evaluation were 
typically detained 30–60 days. Assessments were conducted during the detention period 
prior to the youth’s disposition hearing (i.e., sentencing). Youth were typically referred for 
psychological testing when probation officers were considering a correctional facility for the 
youth to serve their sentence, such as a residential or prison placement or when they had 
suspicions of mental health or substance-related problems that might impair the youth’s 
judgment. Youth were detained under a variety of charges, but most carried charges of 
delinquency unrelated to substance use (e.g., theft, criminal mischief,) or violent offenses 
(e.g., battery) (see Table 1). Only 28 youth (12%) in the current sample carried substance-
related charges. As a significant proportion of youth (42%) were charged with more than one 
offense, only 9 youth in the current sample were exclusively charged with a substance-
related offense.
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Following referral, a licensed clinical psychologist or supervised doctoral student reported to 
the Juvenile Detention Center or the youth’s current placement (residential facility or home 
detention) to complete a psychological assessment. If youth refused the assessment, it was 
not conducted and the court was notified. We do not have data on how many youth may have 
refused the assessment. After youth consented to the psychological assessment, a clinician 
conducted a clinical interview guided by the Youth Level of Service/Case Management 
Inventory (YLS/CMI) (34, 35) to assess for substance use and diagnoses of mental illness, as 
described above, and administered an assessment battery, which included the YSR, SASSI-
A2, WISC-IV, and other measures unrelated to the present study that were used to aid 
diagnosis (e.g., Minnesota Multiphasic Personality Inventory-Adolescent, Child Depression 
Inventory, Child Behavior Checklist). The clinician composed a psychological assessment 
report for each youth, which was submitted to the court. Following IRB approval, two 
trained research assistants coded and de-identified the assessment reports for each youth. An 
additional 20% of the data was re-coded by a third coder; any discrepancies were reconciled 
before data analysis.
Data Analysis
All analyses were performed in SPSS 24.0. Preliminary analyses confirmed that all 
continuous variables met assumptions of normality, with one-way ANOVAs and Chi square 
tests used to examine whether demographic and other study variables differed by cannabis 
use typology using. Cannabis use typology was dummy coded with cannabis only as the 
reference group for all analyses. Multiple linear regression analyses were used to examine 
the relationship between cannabis use typology and intellectual functioning, internalizing 
symptoms, externalizing symptoms and substance-related problems. Analyses for 
intellectual functioning controlled for race, school enrollment, and IEP given consistent 
evidence of lower scores on IQ tests among racial/ethnic minority youth (36) the positive 
association between school enrollment and IQ scores (37), and the negative association 
between curricular modifications (such as IEPs) and IQ scores (38). Gender and age were 
not controlled for as WISC-IV scores are normed for gender and age. All other linear 
regression analyses controlled for race, gender, and age. The models examining substance-
related problems and SUD also controlled for family and peer risk, and attitudes related to 
substance use due to their associations with adolescent substance use (39, 40). Finally, 
multiple logistic regression analysis was used to examine diagnosis of a SUD from age, 
gender, race, family/peer risk, substance use attitudes (again, due to the well-established 
associations of these factors with substance use) (36, 37) and cannabis use-typology. Model 
fit for linear regression was analyzed by examining change in adjusted R2 values after the 
addition of the typology variables to the models. Fit was improved for all models except that 
examining PSI. Model fit for the logistic regression was analyzed using a Hosmer and 
Lemeshow test, which suggested good model fit (x2 = 10.49, p = .232).
Case-wise deletion was used to account for missing data, so sample size varied by variable 
examined (see Table 2 for sample sizes for each variable). Most missing data is on the 
WISC-IV, as some youth were assessed with other instruments for intellectual functioning 
(e.g., Kaufman Brief Intelligence Test, Wechsler Adult Intelligence Scale). There were no 
differences between participants with and without data on any of the other variables of 
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interest (i.e., substance use and psychological problems). Demographic covariates also were 
not significantly associated with missing data.
Results
C+A use made up the largest cannabis use typology (43.3%), followed by CO use (30.7%), 
C+A+O use (20.6%), and C+O use (5.5%). There were no significant differences between 
cannabis-use typology based on age (F [3, 234] = 11.41, p = .068) or gender (x2 = 2.87, p = .
413, V = .11). However, significant differences were observed by race (x2 = 26.84, p < .001, 
V = .34). White adolescents were more likely to use C+A+O and C+O than non-White 
adolescents whereas non-White adolescents were more likely to use CO and C+A. See Table 
2 for cannabis use typologies by demographic characteristics and study variables.
Intellectual Functioning
Controlling for race, school enrollment and special education status (IEP), results of linear 
regression analyses revealed significant differences only for the PRI subscale of the WISC-
IV, such that being in the C+A+O group compared to the CO group was associated with 
lower PRI scores (ß = −.22, p = .030, sr2 = .03) , but membership in this group accounted for 
only 3% of the variance in PRI scores. There were no differences between C+A and CO use 
or C+O and CO use on PRI scores. Similarly, no differences were observed between 
cannabis-use typologies for PSI, VCI, or WMI scores. See Table 3 for full regression results.
Symptomology
Controlling for age, gender, and race, linear regression analyses revealed differences in 
internalizing, but not externalizing symptomology. For internalizing problems, being in the 
C+A group compared to the CO group was associated with significantly higher internalizing 
problems (ß = .21, p = .009, sr2 = .03); membership in this group accounted for only 3% of 
the variance in internalizing symptoms. No differences were observed for externalizing 
symptomology.
Substance Use
The relationship between cannabis use typology and substance use problems was examined 
using linear regression whereas its relationship with SUD was examined using logistic 
regression. Controlling for demographics, family/friend risk and substance use attitudes, C
+A use, C+O use, and C+A+O use was significantly associated with substance use problems 
relative to CO use, with these differences accounting for 2%, 4% and 4% of the variance in 
problems, respectively (see Table 3). Controlling for the same factors, C+A+O use was 
associated with increased odds of SUD diagnosis than CO use (OR = 2.85, p = .042, 95% 
CI: 1.04–7.85). There was no difference between C+A and CO use or C+O and CO use in 
odds of SUD diagnosis.
Discussion
The current study examined whether cannabis polysubstance use was related to functional or 
psychological problems among juvenile offenders. Our findings supported the hypothesis 
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that cannabis-use typologies characterized by polysubstance use (C+A+O, C+O, and C+A 
use) were associated with lower intellectual functioning, greater internalizing and 
externalizing symptomology, and greater substance-related problems among a sample of 
high-risk adolescent detainees. These results support recent literature that has identified 
polysubstance use as a risk factor for psychological problems above and beyond the risk 
posed by cannabis use only (15, 19), and highlights the need for screening and intervention 
among juvenile offenders engaged in polysubstance use.
In addition to overall risk posed by polysubstance use among justice-involved youth, we also 
found evidence for differential risk based on type of polysubstance use. First, regarding 
intellectual functioning, adolescents who used C+A+O were found to perform significantly 
worse on tasks of perceptual reasoning relative to those who used CO. This finding was 
unexpected as previous research has found that adolescents engaging in polysubstance use 
show poorer working memory and verbal recall than those using cannabis only, but show 
deficits similar to those using cannabis only in task accuracy on measures of executive 
functioning and visual-motor integration (which may be similar to some PRI measures) (7). 
One potential explanation for these results is that polysubstance use may be a proxy for 
heavier substance use in general, which is more consistently associated with the magnitude 
of intellectual or cognitive impairment, potentially above the effects of substance type (6, 
41).
Second, regarding psychological distress, we found that C+A use, but not C+A+O or C+O 
use, was associated with higher risk for internalizing symptoms of psychological distress 
compared to CO use. These results contradict findings among nationally-representative 
adolescent samples that suggest polysubstance use confers risk for internalizing symptoms 
regardless of frequency (21, 42). Taken with results that C+A+O use was associated with 
higher risk for substance-related problems and SUD, which suggests higher risk behavior, 
and similar effect sizes for all groups, it is plausible that the small group sizes of C+A+O 
and C+O use contributed to their null relationships with psychological distress. However, it 
is also possible that factors contributing to differential cannabis use typologies, also 
contribute to varying risk for internalizing symptoms. For example, we found that family/
friend risk was significantly higher among adolescents in typologies characterized by other 
illicit drug use than those not. It is plausible that family/friend risk drive cannabis use with 
other illicit drug use whereas other risk factors, such as negative affect regulation drive other 
cannabis use typologies, as negative affect motivations are strongly associated with cannabis 
and alcohol use among adolescents (43). Research with larger adolescent samples may 
clarify the relationship between cannabis use typologies and psychological distress among 
justice-involved populations. Nonetheless, the current results suggest that mental health 
screening may be necessary among youth reporting to detention with polysubstance use.
Third, consistent with previous studies, we found that C+A+O use was associated with 
greater odds of SUD diagnosis than CO use; however, contrary to our hypothesis, C+O and 
C+A use was not. Given that in preliminary analyses, the C+A+O group had higher rates of 
SUD than C+A, but not C+O, it is likely that this difference between the C+A+O and CO 
group was driven by the use of other illicit drugs. Prior research suggests that adolescents 
who use multiple substances may be more likely to use with more frequency or in greater 
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quantities than those who use one or two substances (44, 45), thus increasing risk for SUD. 
Our data provides support for this explanation, as youth who used C+A+O and C+O 
reported more substance-related problems than the other two groups. However, our data did 
not consider frequency, severity or quantity of substance use, which suggests more 
variability in risk that our model was unable to capture. Future studies should examine 
variation in psychological risk based on frequency and quantity of polysubstance use to 
determine whether this relationship is dose-response.
Relative to the other groups, C+A+O and C+O users also endorsed greater peer and family 
risk factors for substance use, which have been found to be the primary contributors to heavy 
cannabis and alcohol use among justice-involved youth (46). Future research should 
examine family and peer risk as a mechanism of the relationship between polysubstance use 
and SUD diagnosis among juvenile detainees, as such information would inform whether 
systems approaches are indicated in addition to a substance use intervention. Nonetheless, 
the current results suggest that detained adolescents engaging in polysubstance use may be 
at greater risk for SUD relative to their peers and should be a screening priority among 
justice-involved youth.
There are several strengths to this study, including its examination of retrospective reports of 
polysubstance use rather than use of a single substance, and its use of reliable diagnostic 
measures used by clinicians—both of which improve the study’s generalizability. However, 
the study’s limitations should be considered when interpreting its data. First, the study is 
cross-sectional, so we cannot make any inferences about directionality. Second, although the 
sample size was adequate, the relatively small and unequal group sizes may have limited 
power to detect effects, particularly among the smallest group—C+O. However, regardless 
of subsample sizes, effect sizes were small across analyses in general and relative to other 
studies. For example, studies examining the relationship between polysubstance use and 
psychological problems have found that polysubstance use explains 19–36% of the variance 
in intellectual functioning and internalizing symptoms (7, 21). However, these studies 
compared polysubstance use to non-use unlike the current study and were not conducted 
among justice-involved youth. These small effect sizes suggest that despite significance, 
cannabis use typology may not represent a pertinent covariate of cognitive and psychological 
problems. Third, the C+O group and C+A+O group were more likely to be White and to be 
detained for a drug offense. Although analyses controlled for these potential confounders, 
they may represent other differences between these groups of youth that were not accounted 
for in the current study. Fourth, results likely reflect sampling bias as the sample only 
included youth who were being considered for residential or prison placement, or suspicion 
of a mental health problem, thus representing a particularly high-risk subset of youth (i.e., 
more delinquency, violent behavior, and/or psychological distress). This sampling bias may 
be compounded by missing data on measures of intellectual functioning, which were 
excluded case-wise. Subsequent studies may mitigate this sampling bias by replicating 
findings among youth who are on probation and/or collecting data from all youth who are 
involved in the justice system regardless of suspicion of mental health problems. Fifth, 
because some of the study variables were sub-scales from the same instruments, they are 
likely to be correlated. However, given the limitation of power due to sample size, the 
correlation across variables was not accounted for within our analysis and could have 
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influenced results. Finally, because these psychological assessments were submitted to the 
court, the participants may have been felt pressure to alter their responses in order to appear 
more socially desirable.
Previous research has documented disproportionately high rates of cannabis and 
polysubstance of cannabis with other drugs use among justice-involved youth. Similar 
results were found in the current sample of juvenile detainees with 88% reporting past-year 
cannabis use and 69% of those using cannabis reporting use of alcohol, other illicit drugs, or 
both. The current study suggests that among justice-involved youth, cannabis polysubstance 
use is related to psychological problems, including SUD. Although techniques for substance 
use reduction are needed among justice-involved youth, those engaged in polysubstance use 
may have a greater need for concurrent academic, affective, and behavioral support during 
their transition back to the community given high rates of recidivism among those with co-
occurring substance use and mental health disorders (47). Unfortunately, current research 
suggests that rates of treatment for SUDs and comorbid mental disorders are low among 
U.S. detainees, and even lower among those reporting both cannabis and alcohol use (48). 
The current study suggests that polysubstance use should be designated a priority for further 
mental health screening among detainees. It also highlights the need for accessible, 
evidence-based treatment approaches for substance use and comorbid psychological 
problems in juvenile justice settings, particularly for those engaged in polysubstance use.
Acknowledgments
Funding: This work was supported in part by NIH/NIDA award F31DA044728 to Devin Banks, NIH/NIAAA 
award F31AA024682 to Alexandra Hershberger, NIH/NIDA awards K01DA043654, R25DA035163 & 
P30DA027827 to Tamika Zapolski, and NIH/AHRQ award R01HS024296 to Matthew Aalsma. The funding 
agencies had no role in the study design, analysis of data, writing of the report, or decision to submit the article for 
publication.
References
1. Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE. Monitoring the Future 
national survey results on drug use, 1975–2015: Volume I, Secondary school students Ann Arbor: 
Institute for Social Research, The University of Michigan; 2016.
2. Grigorenko EL, Edwards L, Chapman J. Cannabis use among juvenile detainees: typology, 
frequency and association. Criminal Behaviour and Mental Health. 2015;25(1):54–65. [PubMed: 
24839230] 
3. Racz SJ, Saha S, Trent M, Adger H, Bradshaw CP, Goldweber A, et al. Polysubstance use among 
minority adolescent males incarcerated for serious offenses. Child & Youth Care Forum. 
2016;45(2):205–20.
4. Lynskey M, Hall W. The effects of adolescent cannabis use on educational attainment: a review. 
Addiction. 2000;95(11):1621–30. [PubMed: 11219366] 
5. Chabrol H, Saint-Martin C. Cannabis use and delinquent behaviors in high-school students. 
Addictive Behaviors. 2009;34(2):187–9. [PubMed: 18954942] 
6. Medina KL, Hanson KL, Schweinsburg AD, Cohen-Zion M, Nagel BJ, Tapert SF. 
Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a 
month of abstinence. Journal of the International Neuropsychological Society. 2007;13(5):807–20. 
[PubMed: 17697412] 
7. Winward JL, Hanson KL, Tapert SF, Brown SA. Heavy alcohol use, marijuana use, and concomitant 
use by adolescents are associated with unique and shared cognitive decrements. Journal of the 
International Neuropsychological Society. 2014;20(8):784–95. [PubMed: 25241623] 
Banks et al. Page 10
Am J Drug Alcohol Abuse. Author manuscript; available in PMC 2020 January 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
8. Flory K, Lynam D, Milich R, Leukefeld C, Clayton R. Early adolescent through young adult alcohol 
and marijuana use trajectories: Early predictors, young adult outcomes, and predictive utility. 
Development and Psychopathology. 2004;16(01):193–213. [PubMed: 15115071] 
9. Windle M, Wiesner M. Trajectories of marijuana use from adolescence to young adulthood: 
Predictors and outcomes. Development and Psychopathology. 2004;16(4):1007–27. [PubMed: 
15704825] 
10. McClelland GM, Elkington KS, Teplin LA, Abram KM. Multiple substance use disorders in 
juvenile detainees. Journal of the American Academy of Child & Adolescent Psychiatry. 
2004;43(10):1215–24. [PubMed: 15381888] 
11. Wibbelink CJM, Hoeve M, Stams GJJM, Oort FJ. A meta-analysis of the association between 
mental disorders and juvenile recidivism. Aggression and Violent Behavior. 2017;33:78–90.
12. Leatherdale ST, Ahmed R. Alcohol, marijuana, and tobacco use among canadian youth: Do we 
need more multi-substance prevention programming? Journal of Primary Prevention. 2010;31(3):
99–108. [PubMed: 20352492] 
13. Macleod J, Oakes R, Oppenkowski T, Stokes-lampard H, Copello A, Crome I, et al. How strong is 
the evidence that illicit drug use by young people is an important cause of psychological or social 
harm? methodological and policy implications of a systematic review of longitudinal, general 
population studies. Drugs: Education, Prevention and Policy. 2004;11(4):281–97.
14. Connor JP, Gullo MJ, White A, Kelly AB. Polysubstance use: Diagnostic challenges, patterns of 
use and health. Current Opinion in Psychiatry. 2014;27(4):269–75. [PubMed: 24852056] 
15. Chan GCK, Kelly AB, Carroll A, Williams JW. Peer drug use and adolescent polysubstance use: 
Do parenting and school factors moderate this association? Addictive Behaviors. 2017;64:78–81. 
[PubMed: 27572180] 
16. White A, Chan GCK, Quek L-H, Connor JP, Saunders JB, Baker P, et al. The topography of 
multiple drug use among adolescent Australians: findings from the National Drug Strategy 
Household Survey. Addictive Behaviors. 2013;38(4):2068–73. [PubMed: 23403274] 
17. Green KM, Musci RJ, Johnson RM, Matson PA, Reboussin BA, Ialongo NS. Outcomes associated 
with adolescent marijuana and alcohol use among urban young adults: a prospective study. 
Addictive Behaviors. 2016;53:155–60. [PubMed: 26517712] 
18. Banks DE, Rowe AT, Mpofu P, Zapolski TCB. Trends in typologies of concurrent alcohol, 
marijuana, and cigarette use among US adolescents: an ecological examination by sex and race/
ethnicity. Drug and Alcohol Dependence. 2017;179:71–7. [PubMed: 28756102] 
19. Moss HB, Chen CM, Yi H-y. Early adolescent patterns of alcohol, cigarettes, and marijuana 
polysubstance use and young adult substance use outcomes in a nationally representative sample. 
Drug and Alcohol Dependence. 2014;136:51–62. [PubMed: 24434016] 
20. Tomczyk S, Isensee B, Hanewinkel R. Latent classes of polysubstance use among adolescents—a 
systematic review. Drug and Alcohol Dependence. 2016;160:12–29. [PubMed: 26794683] 
21. Conway KP, Vullo GC, Nichter B, Wang J, Compton WM, Iannotti RJ, et al. Prevalence and 
patterns of polysubstance use in a nationally representative sample of 10th graders in the United 
States. Journal of Adolescent Health. 2013;52(6):716–23. [PubMed: 23465320] 
22. Cha YM, White AM, Kuhn CM, Wilson WA, Swartzwelder HS. Differential effects of delta9-THC 
on learning in adolescent and adult rats. Pharmacology, biochemistry, and behavior. 2006;83(3):
448–55.
23. Sher KJ. Children of alcoholics: A critical appraisal of theory and research: University of Chicago 
Press; 1991.
24. Dierker LC, Vesel F, Sledjeski EM, Costello D, Perrine N. Testing the dual pathway hypothesis to 
substance use in adolescence and young adulthood. Drug and Alcohol Dependence. 2007;87(1):
83–93. [PubMed: 16959436] 
25. Milin R, Halikas JA, Meller JE, Morse C. Psychopathology among substance abusing juvenile 
offenders. Journal of the American Academy of Child & Adolescent Psychiatry. 1991;30(4):569–
74. [PubMed: 1890090] 
26. Volkow ND, Baler RD, Compton WM, Weiss SRB. Adverse health effects of marijuana use. New 
England Journal of Medicine. 2014;370(23):2219–27. [PubMed: 24897085] 
Banks et al. Page 11
Am J Drug Alcohol Abuse. Author manuscript; available in PMC 2020 January 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
27. Wechsler D Wechsler intelligence scale for children–Fourth Edition (WISC-IV). San Antonio, TX: 
The Psychological Corporation; 2003.
28. Achenbach T, Rescorla L. Manual for the ASEBA school-age forms & profiles: an integrated 
system of multi-informant assessment Burlington, VT: University of Vermont. Research Center for 
Children, Youth, & Families. 2001.
29. Gomez R, Vance A, Gomez RM. Analysis of the convergent and discriminant validity of the 
CBCL, TRF, and YSR in a clinic-referred sample. Journal of Abnormal Child Psychology. 
2014;42(8):1413–25. [PubMed: 24824190] 
30. Vreugdenhil C, van den Brink W, Ferdinand R, Wouters L, Doreleijers T. The ability of YSR scales 
to predict DSM/DISC–C psychiatric disorders among incarcerated male adolescents. European 
Child & Adolescent Psychiatry. 2006;15(2):88–96. [PubMed: 16463011] 
31. Miller FG, Renn WR, Lazowski LE. The adolescent substance abuse subtle screening inventory–
second edition (SASSI-A2): User’s guide. 2001.
32. Miller FG, Lazowski LE. The adolescent SASSI-2 manual: Identifying substance use disorders. 
Springville, IN: The SASSI Institute; 2001.
33. American Psychological Association. Diagnostic and statistical manual of mental disorders 
(DSM-5®): American Psychiatric Pub.; 2013.
34. Hoge RD, Andrews DA. Youth Level of Service/Case Management Inventory 2.0 (YLS/CMI 2.0): 
User’s manual. Toronto, Ontario, Canada: Multi-Health Systems; 2011.
35. Andrews DA, Hoge RD, Leschied AW. Youth level of service and case management inventory. 
Toronto, Canada: Multi-Health Systems 2002.
36. Murray C Changes over time in the Black–White difference on mental tests: Evidence from the 
children of the 1979 cohort of the National Longitudinal Survey of Youth. Intelligence. 
2006;34(6):527–40.
37. Barber N Educational and ecological correlates of IQ: A cross-national investigation. Intelligence. 
2005;33(3):273–84.
38. Crim C, Hawkins J, Ruban L, Johnson S. Curricular modifications for elementary students with 
learning disabilities in high-, average-, and low-IQ groups. Journal of Research in Childhood 
Education. 2008 3 1;22(3):233–45.
39. Miech RA, Johnston LD, O’Malley PM, Bachman JG, Schulenberg JE, Patrick ME. Trends in use 
of and attitudes toward marijuana among youth before and after decriminalization: The case of 
California 2007–2013. The International Journal on Drug Policy. 2015;26(4):336–44. [PubMed: 
25662893] 
40. Newlin David B, Miles Donna R, Bree Marianne BM, Gupman Anne E, Pickens Roy W. 
Environmental transmission of dsm‐iv substance use disorders in adoptive and step families. 
Alcoholism: Clinical and Experimental Research. 2006;24(12):1785–94.
41. Randolph K, Turull P, Margolis A, Tau G. Cannabis and cognitive systems in adolescents. 
Adolescent Psychiatry. 2013;3(2):135–47.
42. Felton JW, Kofler MJ, Lopez CM, Saunders BE, Kilpatrick DG. The emergence of co-occurring 
adolescent polysubstance use and depressive symptoms: A latent growth modeling approach. 
Development and Psychopathology. 2015;27(4pt1):1367–83. [PubMed: 26439081] 
43. Patrick ME, Schulenberg JE, O’Malley PM, Johnston LD, Bachman JG. Adolescents’ reported 
reasons for alcohol and marijuana use as predictors of substance use and problems in adulthood. 
Journal of Studies on Alcohol and Drugs. 2011;72(1):106–16. [PubMed: 21138717] 
44. Chun TH, Spirito A, Hernández L, Fairlie AM, Sindelar-Manning H, Eaton CA, et al. The 
significance of marijuana use among alcohol-using adolescent emergency department patients. 
Academic Emergency Medicine. 2010;17(1):63–71. [PubMed: 20078438] 
45. Terry-McElrath YM, O’Malley PM, Johnston LD. Reasons for drug use among American youth by 
consumption level, gender, and race/ethnicity: 1976–2005. Journal of Drug Issues. 2009;39(3):
677–713. [PubMed: 20628558] 
46. Ewing SWF, Houck JM, Bryan AD. Neural activation during response inhibition is associated with 
adolescents’ frequency of risky sex and substance use. Addictive Behaviors. 2015;44:80–7. 
[PubMed: 25532443] 
Banks et al. Page 12
Am J Drug Alcohol Abuse. Author manuscript; available in PMC 2020 January 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
47. Balyakina E, Mann C, Ellison M, Sivernell R, Fulda KG, Sarai SK, et al. Risk of future offense 
among probationers with co-occurring substance use and mental health disorders. Community 
Mental Health Journal. 2014;50(3):288–95. [PubMed: 23765181] 
48. Hunt E, Peters RH, Kremling J. Behavioral health treatment history among persons in the justice 
system: Findings from the Arrestee Drug Abuse Monitoring II Program. Psychiatric Rehabilitation 
Journal. 2015;38(1):7–15. [PubMed: 25799302] 
10. Colins O, Vermeiren R, Vahl P, Markus M, Broekaert E, Doreleijers T. Psychiatric Disorder in 
Detained Male Adolescents as Risk Factor for Serious Recidivism. The Canadian Journal of 
Psychiatry. 2011;56(1):44–50. [PubMed: 21324242] 
Banks et al. Page 13
Am J Drug Alcohol Abuse. Author manuscript; available in PMC 2020 January 08.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Banks et al. Page 14
Table 1
Frequency table of arrest offenses for youth in the sample
Offense Frequency Proportion of Sample
Burglary, trespass, theft, robbery, etc. 117 49%
Disorderly conduct, criminal mischief, criminal recklessness, etc. 50 21%
Battery, assault, use of a weapon against another person 46 19%
Fleeing/resisting law enforcement, escape, interfering with law enforcement, etc. 43 18%
Violation of probation conditions/curfew/confinement/electronic monitoring/etc. 34 14%
Runaway, truancy, leaving home without permission 33 14%
Illegal/dangerous possession of a firearm or other weapon 22 9%
Dealing/selling or possession of illegal substance (not marijuana) 13 5%
Dealing/selling or possession of illegal substance (marijuana) 13 5%
Public consumption/intoxication of alcohol/illegal substance (not marijuana) 10 4%
Kidnapping, criminal confinement 8 3%
Driving without a license, reckless driving, etc. 5 2%
Failure to stop after an accident or personal/bodily injury 3 1%
Criminal gang activity 3 1%
Sexual battery, rape, child molestation 2 1%
Arson 2 1%
Fraud 1 0%
Note. Many youth were charged with more than one offense, so the total number of offenses does not equal the sample size.
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Table 2
Comparison of demographic characteristics and variables by past-year cannabis-use typology
CO
73
(30.7%)
C+A
103
(45.8%)
C+O
13
(5.5%)
C+A+O
49
(20.6%)
Total
238
(100.0%)
p
Age 15.25 (1.40) 15.60 (1.22) 16.15 (.70) 15.55 (1.23) 15.51 (1.27) .068
Male 61 (83.6%) 79 (76.7%) 12 (92.3%) 41 (83.7%) 193 (81.1%) .413
Non-White 63a (87.1%) 85a (83.7%) 6b (46.2%) 26b (51.1%) 180 (75.6%) < .001
Enrollment 50 (68.5%) 80 (77.7%) 10 (76.9%) 29 (59.2%) 169 (71.0%) .065
IEP 19 (26.0%) 28 (26.0%) 3 (23.1%) 7 (14.3%) 57 (23.9%) .350
Drug Offense 5a (6.8%) 9ab (9.1%) 5c (38.5%) 9bc (18.4%) 28 (11.8%) .004
Intellectual Function
VCI (n = 142) 82.23 (11.17) 79.47 (11.17) 81.83 (7.17) 83.04 (13.49) 81.09 (11.64) .479
PRI (n = 137) 91.34 (12.00) 87.69 (11.52) 86.83 (6.71) 85.21 (17.57) 88.45 (13.05) .254
WMI (n = 140) 91.22 (11.66) 86.78 (15.69) 85.17 (11.46) 92.16 (17.43) 89.29 (14.89) .259
PSI (n = 140) 82.09 (11.90) 81.76 (12.49) 79.50 (8.36) 82.08 (10.78) 81.93 (11.90) .966
Symptomatology
Internalizing (n = 229) 56.43 (6.83) 60.24 (10.50) 58.00 (6.84) 59.09 (8.48) 58.71 (9.09) .450
Externalizing (n = 229) 59.69 (9.55) 62.07 (11.03) 67.67 (8.26) 61.90 (10.56) 61.25 (10.47) .425
Substance Use
Family/friend (n = 221) 51.72a (11.97) 52.67a (11.48) 61.33ab (10.54) 58.24b (11.08) 53.90 (11.77) .008
Attitudes (n = 221) 51.75 (10.51) 51.98 (11.47) 56.50 (15.03) 53.24 (8.71) 52.08 (10.73) .813
Problems (n = 222) 52.10a (10.45) 57.34b (12.95) 68.17bc (12.80) 62.92c (11.74) 57.71 (12.86) < .001
SUD 38a (52.1%) 67a (65.0%) 10ab (76.9%) 41b (83.7%) 156 (65.5%) .003
Note: Sample size is indicated where n does not equal 238. P-values are based on omnibus tests. Among variables with significant omnibus tests, 
groups sharing the same superscript are not significantly different at p < .05.
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